Wael Abdel‐Razek

1.7k total citations
35 papers, 642 citations indexed

About

Wael Abdel‐Razek is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Wael Abdel‐Razek has authored 35 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 31 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Wael Abdel‐Razek's work include Liver Disease Diagnosis and Treatment (31 papers), Liver Disease and Transplantation (18 papers) and Hepatitis C virus research (18 papers). Wael Abdel‐Razek is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Liver Disease and Transplantation (18 papers) and Hepatitis C virus research (18 papers). Wael Abdel‐Razek collaborates with scholars based in Egypt, France and United States. Wael Abdel‐Razek's co-authors include Imam Waked, Tamer Fouad, Vincent G. Bain, Samuel S. Lee, Kelly W. Burak, Richard Moreau, Dominique Valla, Dominique Prié, Claire Francoz and Ameet Mandot and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gut.

In The Last Decade

Wael Abdel‐Razek

34 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wael Abdel‐Razek Egypt 14 537 432 190 79 35 35 642
Valeria Descalzi Argentina 7 342 0.6× 281 0.7× 209 1.1× 34 0.4× 25 0.7× 20 434
Ke-Qin Hu United States 10 313 0.6× 206 0.5× 250 1.3× 48 0.6× 8 0.2× 11 468
Andrés E. Ruf Argentina 9 525 1.0× 417 1.0× 335 1.8× 40 0.5× 92 2.6× 20 647
Lia Bellis Italy 13 400 0.7× 328 0.8× 178 0.9× 28 0.4× 8 0.2× 31 582
Ezequiel Mauro Spain 11 347 0.6× 292 0.7× 119 0.6× 11 0.1× 25 0.7× 36 471
W. Debernardi‐Venon Italy 10 756 1.4× 664 1.5× 320 1.7× 67 0.8× 45 1.3× 19 844
Rajesh Gupta India 11 338 0.6× 363 0.8× 314 1.7× 16 0.2× 22 0.6× 22 580
Valentina Valeriano Italy 10 811 1.5× 751 1.7× 439 2.3× 44 0.6× 20 0.6× 14 901
Mariano Cartier Argentina 9 365 0.7× 325 0.8× 151 0.8× 32 0.4× 46 1.3× 13 446
Tea Restuccia Italy 9 881 1.6× 716 1.7× 423 2.2× 176 2.2× 75 2.1× 15 968

Countries citing papers authored by Wael Abdel‐Razek

Since Specialization
Citations

This map shows the geographic impact of Wael Abdel‐Razek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wael Abdel‐Razek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wael Abdel‐Razek more than expected).

Fields of papers citing papers by Wael Abdel‐Razek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wael Abdel‐Razek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wael Abdel‐Razek. The network helps show where Wael Abdel‐Razek may publish in the future.

Co-authorship network of co-authors of Wael Abdel‐Razek

This figure shows the co-authorship network connecting the top 25 collaborators of Wael Abdel‐Razek. A scholar is included among the top collaborators of Wael Abdel‐Razek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wael Abdel‐Razek. Wael Abdel‐Razek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esmat, Gamal, Mohamed Hassany, Wael Abdel‐Razek, et al.. (2024). Obesity prevalence in adults and patients with hepatitis C: results from screening a population of 50 million in Egypt. SHILAP Revista de lepidopterología. 14(1). 3 indexed citations
2.
Ezzat, Sameera, Ivane Gamkrelidze, Asmaa Gomaa, et al.. (2023). Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model. Liver International. 43(7). 1417–1426. 6 indexed citations
3.
Waked, Imam, Kakil Ibrahim Rasul, Wael Abdel‐Razek, et al.. (2023). Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International. 43(10). 2062–2077. 5 indexed citations
4.
5.
Abdel‐Razek, Wael, et al.. (2022). Utility of prognostic scores in predicting short-term mortality in patients with acute-on-chronic liver failure. SHILAP Revista de lepidopterología. 12(1). 3 indexed citations
6.
Attia, Dina, Shereen Abdel Alem, Wafaa Elakel, et al.. (2022). Prevalence and clinical characteristics of patients with metabolic dysfunction‐associated fatty liver disease with hepatitis C virus infection—a population‐based study. Alimentary Pharmacology & Therapeutics. 56(11-12). 1581–1590. 13 indexed citations
7.
Hassany, Mohamed, Wafaa Elakel, Mohamed AbdAllah, et al.. (2022). Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt. Arab Journal of Gastroenterology. 23(4). 259–262. 3 indexed citations
8.
Abdel‐Razek, Wael, et al.. (2022). Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C. PLoS ONE. 17(11). e0276592–e0276592. 2 indexed citations
9.
Abdelsameea, Eman, et al.. (2020). Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients. Expert Review of Anti-infective Therapy. 19(8). 1053–1059. 6 indexed citations
10.
Abdel‐Razek, Wael, Mohamed Hassany, Manal H. El‐Sayed, et al.. (2019). Hepatitis C Virus in Egypt: Interim Report From the World’s Largest National Program. Clinical Liver Disease. 14(6). 203–206. 18 indexed citations
11.
El‐Serafy, Magdy, Marwa Salama, Ehab Kamal, et al.. (2019). Sofosbuvir‐containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment. Liver International. 40(4). 797–805. 15 indexed citations
12.
Abdel‐Razek, Wael, et al.. (2018). Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment. European Journal of Gastroenterology & Hepatology. 31(1). 16–23. 15 indexed citations
13.
14.
Estes, Chris, Wael Abdel‐Razek, Eman Abdelsameea, et al.. (2015). Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Alimentary Pharmacology & Therapeutics. 42(6). 696–706. 64 indexed citations
15.
Abdel‐Razek, Wael, et al.. (2015). Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis. International Journal of Hepatology. 2015. 1–8. 21 indexed citations
16.
Eltabbakh, Mohamed, et al.. (2014). Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting. Medical Oncology. 32(1). 432–432. 19 indexed citations
17.
Coant, Nicolas, Thierry Gustot, Magali Fasseu, et al.. (2011). Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. Journal of Hepatology. 55(4). 784–793. 44 indexed citations
18.
Francoz, Claire, Dominique Prié, Wael Abdel‐Razek, et al.. (2010). Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: Impact on the model for end-stage liver disease score. Liver Transplantation. 16(10). 1169–1177. 133 indexed citations
19.
Fouad, Tamer, Wael Abdel‐Razek, Kelly W. Burak, Vincent G. Bain, & Samuel S. Lee. (2009). Prediction of Cardiac Complications After Liver Transplantation. Transplantation. 87(5). 763–770. 110 indexed citations
20.
Tazi, Khalid A., Wael Abdel‐Razek, Z. Tellier, et al.. (2009). Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study. Hepatology Research. 39(7). 706–715. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Descalzi Breakdown of academic impact, for papers by Ke-Qin Hu Breakdown of academic impact, for papers by Andrés E. Ruf Breakdown of academic impact, for papers by Lia Bellis Breakdown of academic impact, for papers by Ezequiel Mauro Breakdown of academic impact, for papers by W. Debernardi‐Venon Breakdown of academic impact, for papers by Rajesh Gupta Breakdown of academic impact, for papers by Valentina Valeriano Breakdown of academic impact, for papers by Mariano Cartier Breakdown of academic impact, for papers by Tea Restuccia
Rankless by CCL
2026